Related Experiment Video
Updated: Feb 10, 2026
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Renal cell carcinoma
W Kimryn Rathmell1, Paul A Godley
1Division of Hematology/Oncology, University of North Carolina at Chapel Hill, and the Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina 27599, USA.
Purpose Of Review:
Renal cell carcinoma continues to be a devastating cancer, which currently has few effective treatment options. Recent developments in our understanding of the molecular biology of renal cell carcinoma, particularly clear cell renal cell carcinoma, have led to the development of new agents targeting portions of the hypoxic response pathway.
Recent Findings:
Although high-dose bolus interleukin-2 remains the mainstay of treatment for metastatic disease, the number of patients deriving long-term benefit from this treatment are few, and the use of cytokine therapy in the adjuvant setting has been disappointing. However, the expanding use of minimally invasive surgical techniques has continued to improve patient care. Systemic advances include antibody therapeutics such as bevacizumab, which targets vascular endothelial growth factor signaling, as well as emerging small molecule inhibitors of angiogenesis-related signaling events.
Summary:
In addition to progress in surgical techniques and supportive care of patients with renal cell carcinoma, a host of promising targeted therapies for renal cell carcinoma are on the horizon.
Insights
New targeted therapies show promise for renal cell carcinoma (RCC). While current treatments like interleukin-2 have limited long-term benefits, advances in surgery and new agents offer hope for patients with this devastating cancer.
Area of Science:
- Oncology
- Molecular Biology
- Nephrology
Background:
- Renal cell carcinoma (RCC) remains a significant health challenge with limited effective treatments.
- Recent breakthroughs in understanding RCC molecular biology, especially clear cell RCC, are driving new therapeutic strategies.
- Targeting the hypoxic response pathway is a key focus in developing novel RCC treatments.
Purpose of the Study:
- To review current and emerging treatment options for renal cell carcinoma.
- To highlight advancements in surgical techniques and systemic therapies for RCC.
- To discuss the potential of novel targeted therapies for improving patient outcomes in RCC.
Main Methods:
- Review of current literature on renal cell carcinoma treatment.
- Analysis of recent clinical findings in systemic therapies and surgical approaches.
- Evaluation of emerging targeted agents and their mechanisms of action.
Main Results:
- High-dose interleukin-2 offers limited long-term benefits for metastatic RCC.
- Minimally invasive surgical techniques have improved patient care.
- Systemic advances include bevacizumab (anti-VEGF therapy) and small molecule inhibitors targeting angiogenesis.
Conclusions:
- Progress in surgical techniques and supportive care is enhancing RCC patient management.
- Promising targeted therapies are on the horizon for renal cell carcinoma treatment.
- New therapeutic strategies offer hope for improved outcomes in patients with RCC.
More Related Videos
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
01:23Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
01:08Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
01:23Drug Elimination: Non-Renal Routes
01:24Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...